Stix is a direct-to-consumer women’s health brand that sells at-home yeast infection, pregnancy and UTIs tests. Founded in 2019 by Cynthia Plotch and Jamie Norwood, both cofounders’ embarrassing or confusing experiences with women’s health products helped seed the idea for Stix.

And they’ve struck a nerve. Stix’s revenue increased about 88 percent year-over-year in 2021. They also expanded their team and closed a $3.5 million seed round in April.

Both founders attribute this success to their close relationship with their customers, and they say they look at what their customers are saying to guide their products and offerings.

One way they maintain their relationship with customers is through their Real Talk Platform, a medically-backed sexual health editorial resource produced by Stix. The Real Talk covers topics from what to know before taking a pregnancy test to how to deal with infertility issues.

Subscribe to FORBES:

Stay Connected
Forbes newsletters:
Forbes on Facebook:
Forbes Video on Twitter:
Forbes Video on Instagram:
More From Forbes:

Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.

This Multimillion Dollar Company Is Changing The Way Women Buy Health Products | Forbes